Loading...

Zoetis Inc.

ZTSNYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$156.55
$-0.68(-0.43%)

Zoetis Inc. ZTS Peers

See (ZTS) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
ZTS$156.55-0.43%69.4B28.02$5.56+1.20%
TAK$15.12+0.97%47.4B65.52$0.23+3.91%
HLN$10.39-1.10%46.9B24.24$0.43+1.12%
TEVA$16.81-1.15%19B-14.42-$1.15N/A
ITCI$131.87+0.00%14B-180.64-$0.73N/A
RDY$15.10-2.61%12.8B19.65$0.78+0.62%
NBIX$126.55-0.97%12.5B42.96$2.95N/A
CTLT$63.48+0.00%11.5B-27.84-$2.28N/A
VTRS$9.11+2.51%10.7B-2.87-$3.18+5.29%
RGC$18.26-15.99%10B-2019.00-$0.01N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

ZTS vs TAK Comparison

ZTS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ZTS stands at 69.4B. In comparison, TAK has a market cap of 47.4B. Regarding current trading prices, ZTS is priced at $156.55, while TAK trades at $15.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ZTS currently has a P/E ratio of 28.02, whereas TAK's P/E ratio is 65.52. In terms of profitability, ZTS's ROE is +0.51%, compared to TAK's ROE of +0.04%. Regarding short-term risk, ZTS is more volatile compared to TAK. This indicates potentially higher risk in terms of short-term price fluctuations for ZTS.

Stock Price Comparison

Loading...

Frequently Asked Questions

;